Dark
Light
System
Institutional Investment Manager
SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC (CIK: 0001535610) incorporated in Delaware, located at 1011 Links Dr, Miami Beach, FL. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 379 holdings with a total value of $2,427,276,000.
#
Name
Shares
Value ($)
%
Options
Notes
201 TOBIRA THERAPEUTICS INC 174,943 1,690,000 0.07%
202 SAGE THERAPEUTICS INC 40,019 1,694,000 0.07%
203 UNIQURE NV 844 1,726,000 0.07% Call
204 BARCLAYS BK PLC 1,334 1,736,000 0.07% Call
205 BELLICUM PHARMACEUTICALS INCORPORATED 120,094 1,745,000 0.07%
206 ACURA PHARMACEUTICALS INC 743,603 1,747,000 0.07%
207 ImmunoCellular Therapeutics Lt 4,169,243 1,751,000 0.07%
208 OncoSec Medical Inc 340,169 1,752,000 0.07%
209 FOAMIX PHARMACEUTICALS LTD 243,361 1,784,000 0.07%
210 XTL BIOPHARMACEUTICALS LTD 1,149,886 1,794,000 0.07%
211 QUEST RESOURCE HOLDING CORP 3,148,401 1,795,000 0.07%
212 CHINA BIOLOGIC PRODS INC 20,000 1,796,000 0.07%
213 CESCA THERAPEUTICS INC 3,500,037 1,855,000 0.08%
214 COMMUNITY HEALTH SYS INC NEW 43,397 1,856,000 0.08%
215 OVASCIENCE INC 2,200 1,868,000 0.08% Put
216 GLOBUS MED INC 913 1,886,000 0.08% Put
217 SORRENTO THERAPEUTICS INC 2,275 1,909,000 0.08% Call
218 SERES THERAPEUTICS INC 64,775 1,920,000 0.08%
219 DYAX CORP 1,017 1,941,000 0.08% Put
220 ZS PHARMA INC 297 1,950,000 0.08% Call
221 BRAINSTORM CELL THERAPEUTICS 852,348 1,952,000 0.08%
222 VASCULAR SOLUTIONS INC 607 1,967,000 0.08% Put
223 RICEBRAN TECHNOLOGIES 901,973 1,975,000 0.08%
224 PUMA BIOTECHNOLOGY 26,704 2,012,000 0.08%
225 VAPOR CORP DEL 225,387 2,015,000 0.08%
226 CEMPRA INC 73,195 2,038,000 0.08%
227 BIODELIVERY SCIENCES INTL IN 368,641 2,050,000 0.08%
228 REPROS THERAPEUTICS INC 2,777 2,063,000 0.08% Call
229 MIRATI THERAPEUTICS INC COM 60,000 2,065,000 0.09%
230 REPROS THERAPEUTICS INC 2,793 2,075,000 0.09% Put
231 CYTOKINETICS INC 3,106 2,078,000 0.09% Call
232 PUMA BIOTECHNOLOGY INC 288 2,170,000 0.09% Put
233 BIOCRYST PHARMACEUTICALS 1,929 2,199,000 0.09% Put
234 IGNYTA INC COM 252,974 2,221,000 0.09%
235 PARATEK PHARMACEUTICALS INC 117,046 2,224,000 0.09%
236 REDHILL BIOPHARMA LTD 173,550 2,241,000 0.09%
237 INVIVO THERAPEUTICS HLDGS CO 2,608 2,248,000 0.09% Call
238 TRANSENTERIX INC 10,026 2,266,000 0.09% Call
239 INOVIO PHARMACEUTICALS INC 3,965 2,292,000 0.09% Call
240 REGULUS THERAPEUTICS INC COM 356,504 2,332,000 0.10%
241 LA JOLLA PHARMACEUTICAL CO 85,011 2,362,000 0.10%
242 ALEXION PHARMACEUTICALS INC 152 2,377,000 0.10% Call
243 LIPOCINE INC NEW 201,409 2,383,000 0.10%
244 REVANCE THERAPEUTICS INC 815 2,425,000 0.10% Call
245 SANGAMO THERAPEUTICS INCORPORATED 435,225 2,455,000 0.10%
246 REGENERON PHARMACEUTICALS 53 2,465,000 0.10% Put
247 FEI CO 340 2,483,000 0.10% Call
248 OVASCIENCE INC COM 297,955 2,530,000 0.10%
249 MEDGENICS EQUITY WARRANTS EXP 13 FEB 2018 1,453,640 2,544,000 0.10%
250 PLURISTEM THERAPEUTICS INC 1,474,369 2,683,000 0.11%
Page 5 of 8

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065626, filed 2015.11.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.